<
>
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
January 23, 2023
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
January 11, 2022
iCAD Announces Board of Directors Transition
December 8, 2022
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
November 28, 2022
iCAD and Google Health In Strategic Development and Commercialization Agreement
November 21, 2022
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
» View All News »
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
<
>